Direkt zum Inhalt
Merck

Mohs micrographic surgery for the treatment of melanoma.

Dermatologic clinics (2012-07-18)
Andrea M Hui, Michael Jacobson, Orit Markowitz, Norman A Brooks, Daniel M Siegel
ZUSAMMENFASSUNG

For melanoma treatment, the primary goal is complete removal with histologically negative margins. Mohs micrographic surgery (MMS) has been extensively used and studied for the treatment of nonmelanoma skin cancer, particularly at sites where tissue conservation is vital. The use of MMS for melanoma treatment has yet to become widely accepted owing to difficulties in histologic interpretation, among other factors. MMS may offer lower recurrence rates and improved survival when compared with historical controls for standard excision. Continued advances in MMS technique and immunohistochemical staining have allowed the technique to gain further support.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Zinkchlorid, reagent grade, ≥98%
Sigma-Aldrich
Zinkchlorid -Lösung, 0.5 M in THF
Sigma-Aldrich
Zinkchlorid, anhydrous, powder, ≥99.995% trace metals basis
Sigma-Aldrich
Zinkchlorid 0.1 M -Lösung
Sigma-Aldrich
Zinkchlorid -Lösung, 1.0 M in diethyl ether
Sigma-Aldrich
Zinkchlorid, ACS reagent, ≥97%
Sigma-Aldrich
Zinkchlorid, BioReagent, for molecular biology, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
Zinkchlorid -Lösung, 1.9 M in 2-methyltetrahydrofuran
Sigma-Aldrich
Zinkchlorid, 99.999% trace metals basis
Sigma-Aldrich
Zinkchlorid, AnhydroBeads, amorphous, −10 mesh, 99.99% trace metals basis
Sigma-Aldrich
Zinkchlorid, AnhydroBeads, amorphous, −10 mesh, 99.999% trace metals basis